Patents Assigned to Codman & Shurtleff, Inc
-
Publication number: 20090088695Abstract: A catheter for delivery of a therapeutic agent directly into a targeted tissue that reduces or substantially prevents reflux and back flow by providing rigidity and strength via a stylet thereby eliminating the need for a guide or delivery sheath during positioning. The catheter has a flexible proximal section and a substantially rigid distal section formed from a plurality of distal subsections. The proximal and distal sections having decreasing outer diameters starting from the proximal end and advancing towards the distal end. The distal subsection closest to the distal end providing an adjustable flow rate via multiple output ports defined radially therein while the distal end itself is closed off.Type: ApplicationFiled: September 28, 2007Publication date: April 2, 2009Applicant: Codman & Shurtleff, Inc.Inventors: Terri Kapur, Daniel Keeley, Greg Schorn
-
Patent number: 7510533Abstract: A pressure sensing catheter having a pressure sensor and an antenna that is coupled to the pressure sensor, e.g., by a connector, are provided. The pressure sensor can be adapted to measure a pressure surrounding the catheter, and the antenna can be adapted to telemetrically communicate the measured pressure to an external device. In an exemplary embodiment, the antenna, pressure sensor, and/or connector are hermetically sealed, e.g., by the catheter and/or a coating, to prevent the antenna, pressure sensor, and connector from coming into contact with fluid, thereby allowing the catheter to be permanently implanted or otherwise used for long term use. Exemplary methods for manufacturing and using pressure sensing catheters are also provided.Type: GrantFiled: April 11, 2005Date of Patent: March 31, 2009Assignee: Codman & Shurtleff, Inc.Inventors: Christophe Mauge, Alan J. Dextradeur, Daniel J. McCusker, Stefan Meyer, Volker Boedecker, Robert G. Kraus, Max G. Ostermeier
-
Patent number: 7509171Abstract: Methods and devices for removing cationic glutamate or anionic aluminum complexes from brain tissue by applying a voltage to the brain tissue.Type: GrantFiled: April 27, 2005Date of Patent: March 24, 2009Assignee: Codman & Shurtleff, Inc.Inventor: Thomas M. DiMauro
-
Publication number: 20090030526Abstract: A laminated, bioimplantable dural graft product is configured for use as both an onlay graft and a suturable graft. The dural graft product is sufficiently pliable so as to sufficiently conform to a curvature of a tissue surface to which it is applied, such as the curved surface of a meningeal membrane. The use of the graft product can have improved properties, including suture retention strength and fluid impermeability. To use the dural graft product as an implant to replace, reinforce or strengthen bodily tissue, or to act as an adhesion barrier, the dural graft is placed in contact with bodily tissue and conforms to the curvature of the bodily tissue. Sutures can be used to maintain the contact between the dural graft and the bodily tissue.Type: ApplicationFiled: August 22, 2008Publication date: January 29, 2009Applicant: Codman & Shurtleff, Inc.Inventors: Robert E. Sommerich, Laurel R. Macomber
-
Publication number: 20090005720Abstract: Devices and methods for regulating and directing bodily fluids from one region of a patient to another region are disclosed. In general, an apparatus is provided that can include an implantable shunt system and a system controller. The implantable shunt system can have an adjustable valve for regulating the flow of fluid, a sensor element for measuring a physiological characteristic of a patient, and an electromechanical valve actuator that can be adapted to adjust a resistance of the valve. The implantable shunt system can be in electrical communication with the system controller. The system controller can generally be adapted to receive a physiological characteristic of the patient and operate the electromechanical valve actuator to adjust a resistance of the valve. The apparatus can also include an external programming device that is in communication with the system controller.Type: ApplicationFiled: June 29, 2007Publication date: January 1, 2009Applicant: CODMAN & SHURTLEFF, INC.Inventors: Lev Ludin, Christopher Mauge
-
Publication number: 20090005701Abstract: Various methods and devices are provided for removably coupling a sensor assembly to a catheter to measure conditions surrounding the catheter when the catheter is implanted in a patient. In one embodiment, a modular sensor assembly is provided and includes a housing having an antenna therein adapted to be removably coupled to at least a portion of a catheter. The housing can be a closed loop having an opening therethrough. One or more sensors can be coupled to the antenna for measuring conditions surrounding the catheter when the catheter is implanted in a patient. In one embodiment, the housing can be adapted to removably couple to a distal end of the catheter, and the opening of the housing can be adapted to receive the catheter. The antenna can be a loop disposed within the housing.Type: ApplicationFiled: June 29, 2007Publication date: January 1, 2009Applicant: CODMAN & SHURTLEFF, INC.Inventors: Alan Dextradeur, Stephen Wilson, Daniel McCusker
-
Publication number: 20090005703Abstract: Methods and devices useful for monitoring a patient and for monitoring and displaying the value of a physiological parameter are disclosed. In one embodiment, a user interface for a medical monitoring device is provided. The user interface can have a monitoring screen with a current value screen and a trend screen. The current value screen can display a graphical representation of a value of a physiological parameter over time, e.g., over a first time period, and the trend screen can display a graphical representation of a mean value of the physiological parameter over time, e.g., over a second time period. The lengths of the time periods can be adjustable. In some embodiments, an out-of-limit condition for the physiological parameter can be indicated with shading. For example, the current value screen can display shading between a graph line representing the value of the physiological parameter over time and a threshold line which sets the alarm threshold.Type: ApplicationFiled: June 27, 2007Publication date: January 1, 2009Applicant: CODMAN & SHURTLEFF, INC.Inventor: Robert W. Fasciano
-
Publication number: 20080307854Abstract: A method for maintaining a medical device in a sterile atmosphere at a desired temperature during a calibration step is provided. The method includes packaging a medical device and temperature indicator in a sterile container such that the indicator is visible to a user. Next, heat can be applied to the container in order to stabilize the temperature of the container (as indicated by the encased temperature indicator) at room temperature. Once at room temperature, the device can be calibrated while remaining in the sterile atmosphere. A kit including such a container and a set of instructions is also provided. Like above, the container of the kit can include a sterile medical device and temperature indicator such that the device can be maintained in a sterile environment during calibration and/or zeroing. As such, the method and kit allow for increased precision and safety in performing medical procedures.Type: ApplicationFiled: June 18, 2007Publication date: December 18, 2008Applicant: CODMAN & SHURTLEFF, INC.Inventor: Robert G. Kraus
-
Patent number: 7429241Abstract: A dural graft is provided having improved stiffness characteristics relative to conventional dural substitutes. The dural graft can be formed from a collagen material having a stiffness between about 0.1 pounds per inch (lb./in.) and 0.25 lb./in. Relative to the collagen material forming conventional dural graft substitutes, the decreased stiffness of the collagen material of the present dural graft can provide the graft with a relatively improved or increased pliability. As a result of the increased pliability, the dural graft can sufficiently conform to a curvature of a tissue surface to which it is applied, such as the curved surface of a meningeal membrane. The reduced stiffness of the collagen material can also provide for a relatively improved or increased flexibility or elasticity of the dural graft. The increased flexibility of the dural graft minimizes tearing of the graft when handled or manipulated during an implantation procedure.Type: GrantFiled: September 29, 2005Date of Patent: September 30, 2008Assignee: Codman & Shurtleff, Inc.Inventor: Robert E. Sommerich
-
Publication number: 20080214983Abstract: A pressure sensing catheter having a pressure sensor and an antenna that is coupled to the pressure sensor, e.g., by a connector, are provided. The pressure sensor can be adapted to measure a pressure surrounding the catheter, and the antenna can be adapted to telemetrically communicate the measured pressure to an external device. In an exemplary embodiment, the antenna, pressure sensor, and/or connector are hermetically sealed, e.g., by the catheter and/or a coating, to prevent the antenna, pressure sensor, and connector from coming into contact with fluid, thereby allowing the catheter to be permanently implanted or otherwise used for long term use. Exemplary methods for manufacturing and using pressure sensing catheters are also provided.Type: ApplicationFiled: March 31, 2008Publication date: September 4, 2008Applicant: CODMAN & SHURTLEFF, INC.Inventors: Christophe Mauge, Alan J. Dextradeur, Daniel J. McCusker, Stefan Meyer, Volker Bodecker, Robert G. Kraus, Max G. Ostermeier
-
Publication number: 20080208359Abstract: A dural graft is provided having improved stiffness characteristics relative to conventional dural substitutes. The dural graft can be formed from a collagen material having a stiffness between about 0.1 pounds per inch (lb./in.) and 0.25 lb./in. Relative to the collagen material forming conventional dural graft substitutes, the decreased stiffness of the collagen material of the present dural graft can provide the graft with a relatively improved or increased pliability. As a result of the increased pliability, the dural graft can sufficiently conform to a curvature of a tissue surface to which it is applied, such as the curved surface of a meningeal membrane. The reduced stiffness of the collagen material can also provide for a relatively improved or increased flexibility or elasticity of the dural graft. The increased flexibility of the dural graft minimizes tearing of the graft when handled or manipulated during an implantation procedure.Type: ApplicationFiled: May 1, 2008Publication date: August 28, 2008Applicant: CODMAN & SHURTLEFF, INC.Inventor: Robert E. Sommerich
-
Publication number: 20080154215Abstract: A valve that is adapted to control the flow rate of fluid flow from an implantable pump or other fluid delivery device is provided. In general, the valve includes a multi-lumen member that is adapted to receive fluid-flow therethrough, and a restrictor member that is coupled to the multi-lumen member such that the restrictor member is effective to selectively restrict at least a portion of one or more lumens in the multi-lumen member to thereby adjust the flow rate of fluid flowing through the multi-lumen member. The valve can be built into an implantable drug pump to control fluid flow exiting the pump, or alternatively the valve can disposed within a catheter or otherwise coupled to an outlet port in an implantable drug pump to control the flow rate of fluid exiting the drug pump.Type: ApplicationFiled: March 4, 2008Publication date: June 26, 2008Applicant: CODMAN & SHURTLEFF, INC.Inventors: Meir Rosenberg, Douglas MacBride
-
Patent number: 7390310Abstract: A locking assembly is provided to simply and effectively prevent any unintentional adjustment of the adjustable valve mechanism in a fluid flow control device, without compromising the function of the device. The locking assembly generally includes at least one gripping arm for frictionally engaging at least a portion of the adjustable valve mechanism, and an actuating mechanism for controlling the deployment and release of the gripping arm. The locking assembly prevents unintentional adjustments that can adversely affect the pressure settings of the fluid flow control device. In particular, the locking assembly prevents unintentional adjustment, such as may be caused by the presence of a strong external magnetic field. The locking assembly can be easily disengaged, such as through the application or removal of an external mechanical force, to allow a clinician to adjust the pressure settings of the fluid flow control device as necessary.Type: GrantFiled: July 10, 2002Date of Patent: June 24, 2008Assignee: Codman & Shurtleff, Inc.Inventors: Daniel McCusker, Alan J. Dextradeur, Rainuka Gupta, Carleton Bryan Southworth
-
Publication number: 20080127689Abstract: A locking assembly is provided to simply and effectively prevent any unintentional adjustment of the adjustable valve mechanism in a fluid flow control device, without compromising the function of the device. The locking assembly generally includes at least one gripping arm for frictionally engaging at least a portion of the adjustable valve mechanism, and an actuating mechanism for controlling the deployment and release of the gripping arm. The locking assembly prevents unintentional adjustments that can adversely affect the pressure settings of the fluid flow control device. In particular, the locking assembly prevents unintentional adjustment, such as may be caused by the presence of a strong external magnetic field. The locking assembly can be easily disengaged, such as through the application or removal of an external mechanical force, to allow a clinician to adjust the pressure settings of the fluid flow control device as necessary.Type: ApplicationFiled: February 12, 2008Publication date: June 5, 2008Applicant: Codman & Shurtleff, Inc.Inventors: Daniel McCusker, Alan J. Dextradeur, Rainuka Gupta, Carleton Bryan Southworth
-
Publication number: 20080132823Abstract: A self adjusting hydrocephalus valve that continuously drains cerebrospinal fluid at a rate which is proportional to the average pressure difference across the valve. The valve employs a ball-in-cone mechanism having an associated biasing element that is insensitive to high frequency pressure variations for regulating the opening of the valve mechanism. The biasing element includes flexible bellows having a preset tension.Type: ApplicationFiled: December 7, 2007Publication date: June 5, 2008Applicant: CODMAN & SHURTLEFF, INC.Inventor: Meir Rosenberg
-
Publication number: 20080125759Abstract: An implantable drug delivery system includes an infusion pump assembly with a fluid outlet, a fluid delivery pathway extending from the pump outlet to a target tissue site; and a controlled release material unit positioned in the fluid delivery pathway to release a drug or bioactive material into the delivery pathway. The pump assembly delivers fluid as a high flow infusion flow in said pathway, entraining drug material released by the release unit and establishing a pressure gradient at the distal end of the pathway that results in convection-enhanced transport such that the released drug(s) or treatment material enter the target tissue site with enhanced penetration depth and/or concentration. The pump delivers a carrier fluid that may reside in an external or in an implanted reservoir, or that may be an endogenous fluid, such as plasma or CSF.Type: ApplicationFiled: February 1, 2008Publication date: May 29, 2008Applicant: CODMAN & SHURTLEFF, INC.Inventors: David D. Konieczynski, Alan J. Dextradeur, William L. Rohr
-
Patent number: 7367968Abstract: A valve that is adapted to control the flow rate of fluid flow from an implantable pump or other fluid delivery device is provided. In general, the valve includes a multi-lumen member that is adapted to receive fluid-flow therethrough, and a restrictor member that is coupled to the multi-lumen member such that the restrictor member is effective to selectively restrict at least a portion of one or more lumens in the multi-lumen member to thereby adjust the flow rate of fluid flowing through the multi-lumen member. The valve can be built into an implantable drug pump to control fluid flow exiting the pump, or alternatively the valve can disposed within a catheter or otherwise coupled to an outlet port in an implantable drug pump to control the flow rate of fluid exiting the drug pump.Type: GrantFiled: September 5, 2003Date of Patent: May 6, 2008Assignee: Codman & Shurtleff, Inc.Inventors: Meir Rosenberg, Douglas MacBride
-
Patent number: 7354431Abstract: A leveling device for determining the zero pressure point of an external draining system with respect to a patient is provided. The leveling device generally includes a body having a viewing element defining a field of vision, and a reference point indicator spaced apart from the viewing element and disposed within the line of vision. The viewing element and the reference point indicator define a line of sight. The device further includes a horizontal level indicator mated to the body and oriented parallel to the line of sight established by the viewing element and the reference point indicator. The horizontal level indicator is effective to indicate the horizontal alignment of the body with respect to a particular reference point viewed through the viewing element and indicated by the reference point indicator.Type: GrantFiled: March 16, 2005Date of Patent: April 8, 2008Assignee: Codman & Shurtleff, Inc.Inventor: Stephen Ferrer Wilson
-
Patent number: 7351253Abstract: A method of treating Alzheimer's Disease in which intranasal red light devices are used to shine red light upon the brain structures.Type: GrantFiled: June 16, 2005Date of Patent: April 1, 2008Assignee: Codman & Shurtleff, Inc.Inventors: Thomas M. DiMauro, Mohamed Attawia, Sean Lilienfeld, Chantal Holy
-
Patent number: 7334594Abstract: A shunt valve assembly includes an electromechanical brake mechanism that locks a position of a pressure setting mechanism within a shunt valve assembly. The electromechanical brake can maintain the position of the pressure setting mechanism in the presence of a relatively strong magnetic field to maintain a set pressure differential within the shunt valve assembly. In certain cases, the shunt valve requires repositioning of the pressure setting mechanism within the shunt valve assembly to adjust a fluid flow rate through the shunt valve assembly. A clinician can activate an external controller to transmit a signal to the shunt valve assembly through magnetically coupled antennas between the controller and the shunt valve. The shunt valve assembly utilizes the signal to activate the braking mechanism and unlock the pressure setting mechanism. The clinician then operates the controller to non-invasively reposition the pressure setting mechanism and adjust the pressure at which the shunt valve opens.Type: GrantFiled: June 29, 2005Date of Patent: February 26, 2008Assignee: Codman & Shurtleff, Inc.Inventor: Lev Ludin